Abstract:Ensuring the safety and efficacy of chemical compounds is crucial in small-molecule drug development. In the later stages of drug development, toxic compounds pose a significant challenge, losing valuable resources and time. Early and accurate prediction of compound toxicity using deep learning models offers a promising solution to mitigate these risks during drug discovery. In this study, we present the development of several deep-learning models aimed at evaluating different types of compound toxicity, including acute toxicity, carcinogenicity, hERG_cardiotoxicity (the human ether-a-go-go related gene caused cardiotoxicity), hepatotoxicity, and mutagenicity. To address the inherent variations in data size, label type, and distribution across different types of toxicity, we employed diverse training strategies. Our first approach involved utilizing a graph convolutional network (GCN) regression model to predict acute toxicity, which achieved notable performance with Pearson R 0.76, 0.74, and 0.65 for intraperitoneal, intravenous, and oral administration routes, respectively. Furthermore, we trained multiple GCN binary classification models, each tailored to a specific type of toxicity. These models exhibited high area under the curve (AUC) scores, with an impressive AUC of 0.69, 0.77, 0.88, and 0.79 for predicting carcinogenicity, hERG_cardiotoxicity, mutagenicity, and hepatotoxicity, respectively. Additionally, we have used the approved drug dataset to determine the appropriate threshold value for the prediction score in model usage. We integrated these models into a virtual screening pipeline to assess their effectiveness in identifying potential low-toxicity drug candidates. Our findings indicate that this deep learning approach has the potential to significantly reduce the cost and risk associated with drug development by expediting the selection of compounds with low toxicity profiles. Therefore, the models developed in this study hold promise as critical tools for early drug candidate screening and selection.

Quantum to Classical Neural Network Transfer Learning Applied to Drug Toxicity Prediction

Quantum-to-Classical Neural Network Transfer Learning Applied to Drug Toxicity Prediction

QuantumTox: Utilizing quantum chemistry with ensemble learning for molecular toxicity prediction.

Hybrid Quantum Neural Network for Drug Response Prediction

Decoding toxicological signatures through quantum computational paradigm

Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery

Hybrid quantum-classical convolutional neural networks to improve molecular protein binding affinity predictions

A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery

Binding affinity predictions with hybrid quantum-classical convolutional neural networks

Prediction of Protein-Ligand Binding Affinity by a Hybrid Quantum-Classical Deep Learning Algorithm

Toxicity Prediction Method Based on Multi-Channel Convolutional Neural Network

Quantitative Toxicity Prediction via Meta Ensembling of Multitask Deep Learning Models

A Deep Learning Based Multi-Model Approach for Predicting Drug-Like Chemical Compound’s Toxicity

A deep learning based multi-model approach for predicting drug-like chemical compound's toxicity

Efficient Toxicity Prediction via Simple Features Using Shallow Neural Networks and Decision Trees

Toxicity Prediction using Deep Learning

Novel Approach of Deep Learning in Toxicity Prediction

Quantum Machine Learning for Drug Discovery

Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery

Quantum Machine Learning in Drug Discovery: Applications in Academia and Pharmaceutical Industries

Quantum Long Short-Term Memory for Drug Discovery